what is the average weekly weight loss on semaglutide Weight loss not one size fits all. There are Semaglutide Weight Loss Medication Program

For GLP-1 RA therapy, this implies that weight loss in this population likely derives primarily from appetite suppression rather than from correcting pre-existing metabolic abnormalities, informing expectations about therapeutic mechanisms and outcomes

References: Zatorski, H., Saaga, M., & Fichna, J

That difference matters, and it shapes the kind of before and after results you can reasonably expect

FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication

We provide guidance and materials, but the patient remains responsible for coordinating submission

It did sound logical to do remove the screws and repair the labrum all at once, but perhaps that is too aggressive